• Go to navigation
  • Go to content
AstraZeneca Young Minds

You are here

  • Home
  • 2005 Winners
  • United States Bipolar Disorder Category

Astrazeneca global websites

  • AstraZeneca Websites

Main navigation

  • Home
  • 2006 Winners
  • 2005 Winners
    • United States Bipolar Disorder Category
    • United States Schizophrenia Category
    • International Bipolar Disorder Category
    • International Schizophrenia Category
  • 2004 Winners
  • 2003 Winners
  • How to Apply
  • Proposal Evaluation
  • Steering Committee
  • Calendar
  • Sitemap

United States / Bipolar Disorder Category

Title of Winning Proposal: Shared Bipolar/Schizophrenia Susceptibility Genes on Chromosome 8p 

Dr. Falk W. Lohoff’s research interest is in the genetics of bipolar disorder and schizophrenia, in particular in the genetic and phenotypic overlap between the two disorders. His laboratory is conducting genetic case-control association studies of candidate genes in bipolar disorder and schizophrenia in order to identify genetic risk profiles. Current projects include the identification of the vesicular monoamine transporter 1 gene as susceptibility factor for bipolar disorder and schizophrenia.

After receiving his medical education from Humboldt University Berlin and Thomas Jefferson University, Dr. Lohoff pursued residency training in psychiatry at the University of Pennsylvania. During that time he was selected for the NIMH “Clinical Research Scholar Program” at the University of Pennsylvania.

Dr. Lohoff received numerous awards including the Seed Grant Award by the American Medical Association, the NIMH Outstanding Resident Award and the Society for Biological Psychiatry Travel Award. He served as reviewer for multiple journals including the American Journal of Psychiatry, the European Journal of Neurology, Behavior and Brain Function and Neuroscience Letters.

  • Advanced search

Page tools

  • Print
  • Bookmark this page
AstraZeneca

Legal notices

  • Legal notice
  • Privacy policy
  • © AstraZeneca 2009